Literature DB >> 9744672

High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong.

D A Wong1, L K Tong, W Lim.   

Abstract

The genotype of hepatitis C virus (HCV) of 172 HCV-RNA positive serum specimens taken from patients with chronic liver diseases, thalassaemia major, chronic renal failure (CRF), haemophilia and intravenous drug abusers (IVDA) was determined by analysis of the amplified 5'UTR region by genotype-specific oligonucleotide probes and restriction fragment length polymorphism (RFLP). Six different genotypes and subtypes (1a, lb, 2, 3, 4 and 6) were found. Genotype lb was the predominant genotype among patients with chronic liver diseases (69.6%), followed by genotype 6 (18.8%), which was similar to that reported for blood donors in earlier studies. Pronounced differences in the distribution of genotypes were seen between the four risk groups. Patients with CRF had a similar distribution to those with chronic liver diseases, whilst the greatest diversity of genotypes was seen in patients with haemophilia, which was expected since they were given factor VIII manufactured overseas. Genotype 6 was particularly prominent in patients with thalassaemia major (50%) and IVDA (62.5%). It is possible that clonal spread of HCV genotype 6 has taken place among a closed subset of the population in Hong Kong through intravenous drug abuse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744672     DOI: 10.1023/a:1007400304726

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  25 in total

1.  Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

Authors:  V Bhattacherjee; L E Prescott; I Pike; B Rodgers; H Bell; A R El-Zayadi; M C Kew; J Conradie; C K Lin; H Marsden
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

2.  Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers.

Authors:  L Mattsson; A Sönnerborg; O Weiland
Journal:  Liver       Date:  1993-10

3.  Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease.

Authors:  Y Wang; H Okamoto; F Tsuda; R Nagayama; Q M Tao; S Mishiro
Journal:  J Med Virol       Date:  1993-07       Impact factor: 2.327

4.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

5.  Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

Authors:  P Simmonds; F McOmish; P L Yap; S W Chan; C K Lin; G Dusheiko; A A Saeed; E C Holmes
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

6.  Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.

Authors:  J Y Lau; M Mizokami; J A Kolberg; G L Davis; L E Prescott; T Ohno; R P Perrillo; K L Lindsay; R G Gish; K P Qian
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

7.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region.

Authors:  F Davidson; P Simmonds; J C Ferguson; L M Jarvis; B C Dow; E A Follett; C R Seed; T Krusius; C Lin; G A Medgyesi
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

9.  Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome.

Authors:  M Willems; L Sheng; T Roskams; B Ramdani; J M Doutrelepont; F Nevens; P Durez; S Treille; M Adler; V Desmet
Journal:  J Med Virol       Date:  1994-11       Impact factor: 2.327

10.  Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups.

Authors:  H Tokita; H Okamoto; P Luengrojanakul; K Vareesangthip; T Chainuvati; H Iizuka; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

View more
  9 in total

1.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV.

Authors:  D K Wong; D D Dudley; P B Dohrenwend; G M Lauer; R T Chung; D L Thomas; B D Walker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 3.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 4.  New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.

Authors:  Jing Tong; You-wei Wang; Yuan-an Lu
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

Review 5.  Hepatitis C genotype 6: A concise review and response-guided therapy proposal.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong; Tawesak Tanwandee
Journal:  World J Hepatol       Date:  2013-09-27

Review 6.  Sequence diversity of hepatitis C virus: implications for immune control and therapy.

Authors:  Joerg Timm; Michael Roggendorf
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

7.  Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.

Authors:  Ruifeng Yang; Xu Cong; Shaocai Du; Ran Fei; Huiying Rao; Lai Wei
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

8.  A possible geographic origin of endemic hepatitis C virus 6a in Hong Kong: evidences for the association with Vietnamese immigration.

Authors:  Xiaoming Zhou; Paul K S Chan; John S Tam; Julian W Tang
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

9.  Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6.

Authors:  Mun Hyuk Seong; Ho Kil; Jong Yeop Kim; Sang Soo Lee; Eun Sun Jang; Jin-Wook Kim; Sook-Hyang Jeong; Young Seok Kim; Si Hyun Bae; Youn Jae Lee; Han Chu Lee; Haesun Yun; Byung Hak Kang; Kisang Kim
Journal:  Clin Mol Hepatol       Date:  2013-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.